SPG vs UNCY · rev $3.55B vs $195.0M cap
SPG (SPG) versus Unicycive Therapeutics Inc (UNCY) — a side-by-side from cached financials, not a winner call.
SPG (SPG) common stock.
Unicycive Therapeutics Inc (UNCY) is a biotechnology company listed on NASDAQ.
Latest reported SPG revenue for 2026-06-30 was $3.55B. Net income was $1.14B. SPG currently screens at market cap $0.
UNCY does not have a complete income-statement cache yet.
SPG currently screens at market cap $0. UNCY currently screens at market cap $195.0M.
Not investment advice. Open the SPG and UNCY stock pages for the full models.
Not investment advice.